BARBARA GAMEZ CHANG: Open Payments
NPI 1669086401 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,045 in 34 payments from 11 companies in 2025. Trend: 2023 $684 · 2024 $1,352 · 2025 $1,045
Food & beverage: $1,045
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $461 |
| AstraZeneca Pharmaceuticals LP | 3 | $167 |
| GlaxoSmithKline, LLC. | 3 | $137 |
| UCB, Inc. | 3 | $74 |
| ANI Pharmaceuticals, Inc. | 2 | $67 |
| Radius Health, Inc. | 1 | $30 |
| Ascendis Pharma Endocrinology Inc | 1 | $30 |
| Alexion Pharmaceuticals, Inc. | 1 | $28 |
| Genentech USA, Inc. | 1 | $20 |
| Alnylam Pharmaceuticals Inc. | 1 | $16 |
Products named: SKYRIZI, SAPHNELO, BENLYSTA, RINVOQ, Bimzelx, PURIFIED CORTROPHIN GEL, Tymlos, Yorvipath.
Industry payments across FL — which companies pay providers there.
